Skip to main content
. 2023 Feb 4;11(2):358. doi: 10.3390/vaccines11020358

Figure 4.

Figure 4

Changes in Antibody over Time per Vaccine Use for Subjects with COVID-19 Infection History. (A) Antibody responses (µg/mL) in individuals vaccinated with mRNA-1273 at Month 2 (n = 29), Month 6 (n = 29), and Month 9 (n = 25); (B) antibody responses (µg/mL) in those vaccinated with Bnt162b2 at Month2 (n = 16), Month 6 (n = 15), and Month 9 (n = 9) in subjects with a history of prior COVID-19 infection history at baseline. Levels of antibodies in both cohorts did not show statistical declines over time.